Pancreatic Cancer Research

ResearcherTokyo Metropolitan Komagome HospitalActive in the last 2 years

Masataka Kikuyama

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0003-1869-5536; OpenAlex author ID A5055271043. Sources: OpenAlex.

Their work

Papers
18 (first author 7, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
41
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 4 papers · 2019: 3 papers · 2020: none · 2021: none · 2022: 2 papers · 2023: 2 papers · 2024: none · 2025: 2 papers · 2026: 3 papers

Papers 18

  1. Association between autoimmune pancreatitis and pancreatic cancer: a case after long-term steroid therapy. Co-author DOI 10.1007/s12328-026-02398-x↗
  2. Accelerated Pancreatic Volume Loss as a Potential Pre-Diagnostic Imaging Biomarker for Pancreatic Cancer Risk Enrichment: An AI-Assisted Volumetric Study. Co-author DOI 10.3390/cancers18183062↗
  3. Diagnostic Method Advancement to Improve the Prognosis of Pancreatic Ductal Adenocarcinoma. First author DOI 10.3390/diagnostics16142286↗
  4. Focal pancreatic parenchymal atrophy could be a precursor of pancreatic cancer. Co-author DOI 10.1016/j.pan.2025.01.003↗
  5. Focal Pancreatic Parenchymal Atrophy: An Alternative Indicator for Early-Stage Pancreatic Cancer. Co-author DOI 10.1159/000545847↗
  6. The outcome of a multidisciplinary approach incorporating neoadjuvant chemoradiotherapy with S1 for resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ags3.12624↗
  7. A Novel Diagnostic Imaging Method for the Early Detection of Pancreatic Cancer. Co-author DOI 10.3390/diagnostics13122080↗
  8. Comparing the 14-mm uncovered and 10-mm covered metal stents in patients with distal biliary obstruction caused by unresectable pancreatic cancer: a multicente… Last author DOI 10.1007/s00464-021-08342-z↗
  9. Focal pancreatic parenchyma atrophy is a harbinger of pancreatic cancer and a clue to the intraductal spreading subtype. First author DOI 10.1016/j.pan.2022.10.003↗
  10. Proposal for Endoscopic Ultrasonography Classification for Small Pancreatic Cancer. First author DOI 10.3390/diagnostics9010015↗
  11. Advances in Early Detection of Pancreatic Cancer. Co-author DOI 10.3390/diagnostics9010018↗
  12. Surveillance of Individuals with a Family History of Pancreatic Cancer and Inherited Cancer Syndromes: A Strategy for Detecting Early Pancreatic Cancers. Co-author DOI 10.3390/diagnostics9040169↗
  13. Acute obstructive suppurative pancreatic ductitis (AOSPD) in pancreatic cancer treated by nasopancreatic drainage. First author DOI 10.1007/s12328-018-0830-z↗
  14. Multicenter study of early pancreatic cancer in Japan. Co-author DOI 10.1016/j.pan.2017.11.007↗
  15. Hereditary Pancreatitis Showing Numerous Cysts with Pancreatic Cancer. First author DOI 10.2169/internalmedicine.0938-18↗
  16. Early Diagnosis to Improve the Poor Prognosis of Pancreatic Cancer. Co-author DOI 10.3390/cancers10020048↗
  17. A case of pancreatic cancer with severe vomiting treated by endoscopic ultrasound-guided celiac ganglia neurolysis. First author DOI 10.1007/s12328-017-0761-0↗
  18. Acute Pancreatitis as a Possible Indicator of Pancreatic Cancer: The Importance of Mass Detection. First author DOI 10.2169/internalmedicine.54.4068↗

Closest collaborators

The 25 strongest of 41 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kazuro Chiba · 7 shared papers, 2018–2026 · strength 1.35
  2. Jun Nakahodo · 5 shared papers, 2019–2026 · strength 1.15
  3. Goro Honda · 4 shared papers, 2019–2026 · strength 1.13
  4. Terumi Kamisawa · 6 shared papers, 2018–2026 · strength 0.98
  5. Ryogo Minami · 2 shared papers, 2026 · strength 0.53
  6. Shinya Kawaguchi · 5 shared papers, 2017–2022 · strength 0.52
  7. Pradez Sapkota · 1 shared paper, 2026 · strength 0.50
  8. Shuzo Terada · 4 shared papers, 2017–2022 · strength 0.40
  9. Sawako Kuruma · 3 shared papers, 2018–2019 · strength 0.29
  10. Hirotoshi Ishiwatari · 2 shared papers, 2019–2022 · strength 0.26
  11. Hiroyuki Matsubayashi · 2 shared papers, 2019–2022 · strength 0.26
  12. Hiroyuki Ono · 2 shared papers, 2019–2022 · strength 0.26
  13. Masanao Kurata · 1 shared paper, 2026 · strength 0.24
  14. Masakazu Toi · 1 shared paper, 2026 · strength 0.24
  15. Tatsunori Satoh · 2 shared papers, 2018–2022 · strength 0.23
  16. Naofumi Shirane · 2 shared papers, 2017–2022 · strength 0.22
  17. Hideyuki Kanemoto · 2 shared papers, 2018–2019 · strength 0.21
  18. Atsushi Kanno · 2 shared papers, 2018–2019 · strength 0.19
  19. Keiji Hanada · 2 shared papers, 2018–2019 · strength 0.19
  20. Atsushi Masamune · 2 shared papers, 2018–2019 · strength 0.19
  21. Masayuki Kitano · 2 shared papers, 2018–2019 · strength 0.19
  22. Sara Hayakawa · 1 shared paper, 2023 · strength 0.18
  23. Masaru Matsumura · 1 shared paper, 2023 · strength 0.18
  24. Yasuji Seyama · 1 shared paper, 2023 · strength 0.18
  25. Yusuke Ome · 1 shared paper, 2023 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.